NASDAQ:FPRX
Delisted
Five Prime Therapeutics Stock News
$38.00
+0 (+0%)
At Close: May 27, 2022
Five Prime Therapeutics (FPRX) Expected to Beat Earnings Estimates: Should You Buy?
01:38pm, Wednesday, 03'rd Mar 2021
Five Prime Therapeutics (FPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Five Prime Therapeutics to Participate in the Cowen 41st Annual Health Care Conference
05:00pm, Friday, 26'th Feb 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Five Prime Therapeutics to Participate in the Cowen 41st Annual Health Care Conference
Five Prime Therapeutics to Participate in the SVB Leerink 10th Annual Global Healthcare Conference
06:00pm, Monday, 22'nd Feb 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Five Prime Therapeutics to Participate in the SVB Leerink 10th Annual Global Healthcare Conference
Five Prime Therapeutics to Participate in Guggenheim Healthcare Talks 2021: Oncology Day
09:25am, Friday, 05'th Feb 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Five Prime Therapeutics to Participate in Guggenheim Healthcare Talks 2021: Oncology Day
Five Prime Therapeutics: Understanding Bemarituzumab
03:06pm, Thursday, 10'th Dec 2020
Overview of Five Prime Therapeutics.
These Were the 5 Best Cancer Stocks Of 2020
08:29am, Monday, 07'th Dec 2020
Biotech investors had more than just vaccines to think about this year.
Have $1,000? Here Are 3 Top Healthcare Stocks to Buy in December
04:00pm, Saturday, 05'th Dec 2020
There are plenty of healthcare stocks that have seen share growth this year. Here are three lesser-known stocks that have the potential to continue that growth this month and beyond.
Five Prime Therapeutics: Primed For Growth
08:00am, Friday, 04'th Dec 2020
Five Prime Therapeutics declared outstanding results last month and went up nearly 400%. Given the market potential, there may still be considerable upside.
2 Biotech Stocks That Could Double Your Money
10:00am, Tuesday, 17'th Nov 2020
Aptose Biosciences and Five Prime Therapeutics both have explosive growth potential.
Five Prime Announces Pricing of Upsized Public Offering of Common Stock
10:00pm, Thursday, 12'th Nov 2020
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Five Prime Therapeutics, Inc. (Nasdaq: FPRX), announced today the pricing of an underwritten public offering of 7,200,000 shares of its common stock at a
You've Probably Never Heard of the Stock Market's Biggest Winner Wednesday
01:24pm, Wednesday, 11'th Nov 2020
And as a bonus, find out which much-loved stock let its shareholders down.
Five Prime Therapeutics: 6 Things for FPRX Stock Investors to Know Now
12:22pm, Wednesday, 11'th Nov 2020
Shares of FPRX stock are skyrocketing on Wednesday after the company reported positive results from its stomach cancer treatment trial. The post Five Prime Therapeutics: 6 Things for FPRX Stock Invest
7 Biotech Penny Stocks Worth a Gamble
11:50am, Wednesday, 11'th Nov 2020
With the pandemic drawing much attention toward biotech stocks, there are some interesting ideas among in the small-cap field, but only if you understand the severe risks involved. The post 7 Biotech
Why Five Prime Therapeutics Stock Skyrocketed on Wednesday
10:27am, Wednesday, 11'th Nov 2020
Five Prime Therapeutics Inc. (NASDAQ: FPRX) shares more than tripled on Wednesday after the company announced positive topline results from its gastric cancer study.
Why This Tiny Biotech Stock Just Skyrocketed 285% In Bullish Volume
10:21am, Wednesday, 11'th Nov 2020
Shares of Five Prime Therapeutics skyrocketed early Wednesday after the tiny biotech stock's stomach cancer treatment, a drug known as bemarituzumab, passed muster in a midstage test. The post Why Thi
